constraining patent_expiry_europe
saveStemline Therapeutics Inc — SL-901 (Constraining Patent Expiry (Europe))
community read0 votes
Therapy area: Oncology, Undisclosed. Indication: Lung Cancer, Solid Tumor, Unspecified Rare Disease
Therapy area: Oncology, Undisclosed. Indication: Lung Cancer, Solid Tumor, Unspecified Rare Disease
comments(0)
5-min edit window · permanent after that